40 results about "Sexual arousal" patented technology

Systems and methods for interactive treatments of female sexual disorders are presented. A programmable sexual stimulation device is provided, which transmits and receives data relating to the use and function of the device. The sexual stimulation device may be programmed to implement a particular combination of mechanical actions which have been customized by a user or a health care professional involved in the treatment or preference of the user. The device may also collect data on the type of mechanical actions input by the user and transmit the data to a remote location for viewing by the user or the healthcare professional. The device may also communicate with external devices which aid in the treatment programs, such as audio or image display devices which can coordinate the function of the sexual stimulation device with the presentation of audio or visual information to provide additional sources of sexual arousal to the user.

A female sexual wellness device configured to provide stimulation frequencies targeting a specific nerve response of clitoral tissue. In one embodiment, the device can alternatively include a motor that creates an oscillatory air pressure wave.

A non-invasive method of altering vaginal blood flow in a female individual to augment or lessen sexual arousal is provided. The method involves administering an individual odorant or odorant mixture for inhalation that is sufficient to alter vaginal blood flow of the female by about −20% to about +30% compared to a baseline vaginal blood flow without inhalation of the odorant. Also provided is a method for screening an odorant for its capacity to increase or decrease vaginal blood flow, and an article of manufacture, or kit, containing an odorant and instructions for its use in altering vaginal blood flow.

This inventon relates to compositions for stimulating sexual arousal in males and females and for male and female sexual arousal enhancement, and more particularly to the formaton of and treatment with said arousal, spermicidal and fungicidal composition to a male and female.

Methods and compositions for enhancing female sexual arousal and treating female sexual dysfunction utilize L-arginine or equivalents and/or derivatives thereof, and an agent that enhances the activity of the L-arginine or equivalent thereof. These enhancing agents include niacin and/or nicotinamide. Niacin and/or nicotinamide, in combination with L-arginine or its equivalent allow a desired amount of nitric oxide to be delivered or generated at the female genitals in order to increase vasodilation and blood flow to the area to enhance sexual arousal and/or pleasure and to treat sexual dysfunction.

Temperature-sensitive mood stones or beads are incorporated into lingerie at positions that indicate sexual arousal to indicate by observation the state of arousal of the individual wearing the lingerie. In one embodiment, the mood beads are located adjacent the groin area for women's panties and at various erogenous zones of a brassiere, including cups and straps.

Systems and methods are provided for treating a sexual disorder such as erectile dysfunction (ED) or female sexual arousal disorder (FSAD). An electrical stimulation system may include an implantable stimulation unit, an external patient controller, and an external physician controller. The implantable stimulation unit has an array of electrodes disposed on one or more flexible substrates configured to conform to a patient's anatomy at the pelvic plexus. Post-implantation, the physician controller may direct the stimulation unit to stimulate with select electrode(s) of the array to determine which electrode configuration provides optimal sexual arousal. The patient controller may be used to cause the stimulation unit to stimulate using the optimal electrode configuration at desired times.

The present invention describes a method for the treatment of attention deficit hyperactivity disorder (ADHD), conduct disorder, alcohol addiction, tobacco addiction, nicotine addiction, parkinsonism including Parkinson's disease, female and male orgasmic disorders, female and male sexual arousal disorders, hypoactive sexual desire disorder, and disorders characterized by anxiety and/or depression. In this method, a therapeutically effective, nontoxic dose of a 4′,4″-substituted 3α-(diphenylmethoxy) tropane analog or a pharmaceutically acceptable salt thereof is administered to the patient in need of such treatment.

A libido measurement icon displays messages related to a partner user's sexual arousal level on the display of a user's devices, such as Smartphone or tablet, having Internet connectivity. When a user or partner user activates the icon, the icon will display messages received from partner users related to the partner user's current level of sexual arousal and will allow a user to submit the user's own libido level (a “libido score”) to a partner user via the libido measurement system's messaging function.

The invention provides a traditional Chinese and western medicine combined compound preparation which is applied to prevention and/or treatment of female sexual dysfunction and comprises epidermal growth factors, estrogen and glycerin. The invention further provides application of the compound preparation. The invention relates to the field of pharmaceutical preparations, in particular to the application in improving female sexual arousal and enhancing sexual desire and in products thereof, the application in improving female vaginal lubrication disorder and relieving vaginal dryness and in products thereof, the application in improving female sexual intercourse pain and improving sexual satisfaction and in products thereof and the application in preventing and/or treating female sexual dysfunction and in products thereof. The invention provides a basis for preventing and treating female sexual dysfunction by directly utilizing the compound preparation.

A dosage chart for the treatment of achieving and maintaining male erectile response regardless of state of mind, occurrence of ejaculation or lack of sexual arousal of an object. The chart including a general, physical, and psychological conditions of the object; an age of the object; at least one pharmaceutical composition of one or more erection-producing agents; and a first corresponding dosage of the pharmaceutical composition to the age group and the general, physical, and psychological conditions of the object. The dosage chart further including observation of the object after receiving the corresponding dosage; and adjustment of a second dosage of the pharmaceutical composition.

The invention provides a method for preventing or treating male erectile dysfunction or female sexual arousal disorder by administering an effective amount of one or more factors from a group of factors including vascular endothelial growth factor, brain-derived neurotrophic factor, basic fibroblast growth factor, neurotrophin-3, neurotrophin-4, or angiopoietin-1, wherein the factor is a full length protein or a nucleic acid encoding the factor, or a functional derivative or fragment thereof, or an agent that enhances production and/or male erection or female sexual arousal stimulating function of the factor(s). Combinations, kits, and combinatorial methods are also provided.

An erotic dream induction apparatus includes an inflatable air bladder, such as a rubber balloon, to induce sexual arousal via genital stimulation. The air bladder is brought into contact with either the penis or vagina of the user, and/or is inserted into the anus and/or vagina of the user. In one embodiment, the air bladder is brought into contact with the penis, vagina, and/or anus of the user by being maintained in position near, against, or around the penis, vagina, and/or anus by means of straps or pockets in stimulation underwear, such that when the air bladder is inflated, the air bladder makes contact with at least a portion of the penis, vagina, and/or anus of the user. The air bladder is repeatedly inflated and deflated by means of pumps and/or valves.

The present invention provides methods of increasing sexual arousal and performance behaviors in female mammals by administration of a therapeutically acceptable amount of a positive modulator of an AMPA-type glutamate receptor.

The invention relates to a kombucha fermentation lubricant and a preparation method thereof. The kombucha fermentation lubricant is prepared from the following materials in parts by weight: 15-25 parts of kombucha fermentation broth, 30-40 parts of glycerinum, 0.5-1.5 parts of hyaluronic acid, 1-2 parts of water-soluble camellia oleosa seed oil, 0.3-0.5 part of Ylang essential oil, 0.5-1 part of hydroxyethyl urea, 0.5-1 part of kombucha fermentation film modifier, and 30-50 parts of deionized water. The hyaluronic acid lubricant disclosed by the invention is prepared from natural plants, is convenient to carry and use, and can effectively clean and improve the sexual arousal effect, thus being a lubricant product which can be used for a long time.

This invention relates generally to the field of urology. In particular, the invention provides a method for preventing or treating male erectile dysfunction or female sexual arousal disorder, which method comprises administering an effective amount of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), basic fibroblast growth factor (bFGF), or a functional derivative or fragment thereof, or a nucleic acid encoding said VEGF, BDNF or bFGF, or functional derivative or fragment thereof, or an agent that enhances production and/or erection or sexual arousal stimulating function of said VEGF or BDNF or bFGF to a mammal, wherein such prevention or treatment is desirable, thereby preventing or treating said male erectile dysfunction or female sexual arousal disorder in said mammal. Combinations, combinatorial methods and kits for preventing or treating male erectile dysfunction or female sexual arousal disorder are also provided.

Compositions and methods for stimulating erogenous zones of female and male subjects are disclosed. More particularly, the present disclosure relates to compositions for topical application to the female and male genitalia that increase cell membrane excitability and to methods of using the compositions for treating sexual dysfunction and enhancing sexual arousal and facilitating orgasm.